Global Digital Health Market Expected to Garner $1,045.8 Billion in Revenue and Grow at a CAGR of 33.4% during the Estimated Timeframe 2020-2027 | Research Dive
10 oct. 2022 09h02 HE
|
Research Dive
New York, USA, Oct. 10, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global digital health market is anticipated to generate a revenue of $1,045.8 billion by...
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
18 août 2022 10h30 HE
|
Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...
Pharmaceutical Drug Delivery Market Revenue to Cross $2296.17 Bn, Globally by 2027 at 6.6% CAGR | Exclusive Report by The Insight Partners
26 juil. 2022 10h30 HE
|
The Insight Partners
New York, July 26, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by...
Community Org Kicks Off Conquer Diseases Movement
10 juin 2022 17h00 HE
|
Life ProLong Center
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- The Life ProLong Center, a community well-being-oriented organization, officially kicked off its "Conquer Diseases" event in June 2022. Since the World...
Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30%
02 déc. 2021 10h00 HE
|
Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc., a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference
10 nov. 2021 16h15 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
11 août 2021 09h00 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
IMAC Holdings to Present at the LD Micro Virtual Invitational Conference on June 8, 2021
02 juin 2021 09h02 HE
|
IMAC Holdings, Inc.
Brentwood, Tenn., June 02, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation...
IMAC Regeneration Centers Annual Analysis Shows 81% of Patients Report Improvement in Functional Outcomes from Treatment of Musculoskeletal Conditions
27 mai 2021 09h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., May 27, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...
IMAC Holdings to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on Tuesday, June 1, 2021
26 mai 2021 06h01 HE
|
IMAC Holdings, Inc.
Brentwood, Tenn, May 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation...